drugset / Trial / NCT06665230

A Clinical Study of MK-6552 and Modafinil in Healthy Men (MK-6552-005)

NCT06665230

Phase 1 Completed 12 enrolled Merck Sharp & Dohme LLC
NaSingle-groupOpen-labelTreatment

Summary

The goal of this study is to learn what happens to MK-6552 in a person's body over time. Researchers will compare what happens to levels of MK-6552 in people's blood when it is taken with and without modafinil. Researchers also want to learn about the safety of MK-6552 taken with and without modafinil and if people tolerate it.

Timeline

Start
2023-09-20
Primary completion
2023-11-20
Completion
2023-11-20

Drugs

EvaluationDrugModalityDoseRoute
Subject MK-6552 Unknown Oral
Subject Modafinil Small molecule Oral

Indications